ISMP (US) Contact Us Feedback
     Search:  
   

ISMP Canada News

January 2001



  • Abboject products from Abbott Laboratory have
    been available to Canadian hospitals since the middle of December 2000. Now
    Canadian healthcare professionals have a choice to purchase the Abboject
    product line or the Lifeshield product line.





  • Bayer Canada recently informed ISMP Canada that
    the work had been initiated with their international source plant in Italy
    to make the label change on Cipro Oral Liquid. Specification on the label
    changes is presently worked on. Progress and the subsequent change of label
    will be updated to ISMP Canada in the near future.





  • ISMP Canada is currently examining other
    concerns on labels that have been reported. The concerns involve primarily
    on injectable products. A meeting is being organized by ISMP Canada inviting
    pharmacists, physicians, manufacturers, CSA International and Health Canada
    to re-visit the pharmaceutical label requirement and suggested guidelines
    for the purpose of improving patient safety. Practitioners and hospitals are
    encouraged to forward label and package concerns to ISMP Canada for
    corrective actions.





  • Although many Canadians practitioners have found
    the biweekly Medication Safety Alert! newsletter published by ISMP (US) very
    informative and useful, ISMP Canada is planning to launch the Canadian
    version which should include more Canadian contents and issues which are
    relevant to the Canadian practice. Alert on mix-up of Canadian brand drug
    names; label and packaging problems are just some examples. Plans are
    underway to establish the proper infrastructure and resource to handle our
    monthly newsletter.





  • ISMP Canada has just completed a prototype of a
    medication error reporting and analysis software program (Analyse-err). The
    Analyse-err program has two components: an objective factual reporting; and
    a root-causes analysis exercise. It is being tested by four Canadian
    hospitals (two teaching and two community hospitals) for a period of about
    three months. Results of evaluation and feedback will be presented at the
    two day conference in April (see the education calendar below).





  • In partnership with The CQI Network, ISMP Canada
    will be sponsoring a major two day conference titled: "Breaking the
    Silence: Error in Health Care" on April 20 and 21, 2001 in Toronto.
    International reputable speakers will include Michael Cohen, David Bates,
    David Cousin (UK) and others. The conference planning committee is being
    chaired by Cynthia Majewski and Tom Paton. The program is being finalized
    and should be available to all Canadian healthcare professionals and
    organizations in the near future. Stay tuned.





  • A glance of all educational programs on patient
    safety involving ISMP Canada for the next few months:



    • Medication Errors: Implementing Changes for Improved Patient Safety
      sponsored by OHA, Toronto, January 31, 2001.



    • Medication Safety and its Impact on Hospitals, A breakfast satellite
      session at the Canadian Society of Hospital Pharmacists' Professional
      Practice Conference, Toronto, February 6, 2001.



    • Risk Management for Long Term Care Facilities, organized by Infonex,
      Toronto, March 5-6, 2001.



    • Humber College Annual Pharmacy Technician Conference, Toronto, March
      10-11, 2001.



    • Safe Medication Workshop sponsored by Orillia Soldier Memorial Hospital,
      Orillia, March 30, 2001.



    • Breaking the Silence: Error in Health Care conference, co-sponsored by
      ISMP Canada and The CQI Network, Toronto, April 20-21, 2001.